← back to search

Kate Wyburn

University of Technology Sydney · AU
Area of research
Transplantation · Public Health, Environmental and Occupational Health
Research interest
Research interests include Renal Transplantation Outcomes and Treatments, Organ Donation and Transplantation, Organ Transplantation Techniques and Outcomes, and Renal and Vascular Pathologies.
h-index
22
citations
3,057
works
159
NIH funding
primary concept
Medicine
email

Recent publications

Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease
Nephrology Dialysis Transplantation 2025cited by 17position: middledoi
A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody‐Mediated Rejection
Clinical Transplantation 2024cited by 19position: middledoi
Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial
The Lancet 2023cited by 74position: middledoi
Immune checkpoint inhibitors in kidney transplant recipients: a multicentre, single-arm, phase 1 study
The Lancet Oncology 2022cited by 83position: middledoi
Sex-Based Differences in Risk Factors and Complications of Chronic Kidney Disease
Seminars in Nephrology 2022cited by 37position: middledoi
Patient needs and priorities for patient navigator programmes in chronic kidney disease: a workshop report
BMJ Open 2020cited by 59position: middledoi
Cancer mortality in kidney transplant recipients: An Australian and New Zealand population‐based cohort study, 1980–2013
International Journal of Cancer 2019cited by 51position: middledoi
The Treatment of Antibody-Mediated Rejection in Kidney Transplantation
Transplantation 2018cited by 162position: middledoi
Infectious Disease Transmission in Solid Organ Transplantation: Donor Evaluation, Recipient Risk, and Outcomes of Transmission
Transplantation Direct 2018cited by 89position: middledoi
A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor
American Journal of Transplantation 2018cited by 58position: middledoi
Preconditioning Therapy in ABO-Incompatible Living Kidney Transplantation
Transplantation 2015cited by 79position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nicole De La Mata · The University of Sydney2 papers (2019–2022)Melanie Wyld · The University of Sydney2 papers (2018–2022)Jonathan C. Craig · Murdoch Children's Research Institute2 papers (2015–2020)Angela C Webster · The University of Sydney2 papers (2019–2022)Germaine Wong · Children's Hospital at Westmead2 papers (2015–2020)Fuad S. Shihab · University of Utah1 papers (2018–2018)Fabian Halleck · Humboldt-Universität zu Berlin1 papers (2024–2024)Vincent Lee · Edward Via College of Osteopathic Medicine1 papers (2020–2020)Patrick J. Kelly · The University of Sydney1 papers (2019–2019)Shaundeep Sen · The University of Sydney1 papers (2020–2020)Armando Teixeira-Pinto · The University of Sydney1 papers (2020–2020)Angela Ju · The University of Sydney1 papers (2020–2020)Emma O’Lone · The University of Sydney1 papers (2022–2022) · 1 papers (2018–2018) · 1 papers (2024–2024)Carmen Lefaucheur · California Institute for Regenerative Medicine1 papers (2024–2024) · 1 papers (2020–2020)Anne E. Taylor · University of Birmingham1 papers (2022–2022)Julie Johnston · Royal Adelaide Hospital1 papers (2022–2022)Tracey Ying · The University of Sydney1 papers (2018–2018)